COMMONWEALTH EQUITY SERVICES, LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 312272 WALTHAM, MA

Position in CAPR

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$813,260

+$54,589 QoQ

Shares Held

26,752

+1.8% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Healthcare · as of Mar 31, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $113,564,491 across 120 Biotechnology names. CAPR ranks #27 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,972	$24,547,196
2	REGN	Regeneron Pharmaceuticals, Inc.	16,385	$12,659,706
3	EXEL	Exelixis, Inc.	173,762	$7,452,652
4	TGTX	Tg Therapeutics, Inc.	180,285	$5,989,067
5	TARS	Tarsus Pharmaceuticals, Inc.	80,892	$5,674,573
6	CRSP	CRISPR Therapeutics AG	78,488	$3,733,674
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,577	$3,499,611
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,076	$3,453,265

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$813,260	26,752	+1.8%	Shares	Sole	2026-04-27
2025-12-31	$758,671	26,288	-14.8%	Shares	Sole	2026-02-12
2025-09-30	$222,500	30,860	-0.0%	Shares	Sole	2025-10-22
2025-06-30	$306,459	30,862	-0.0%	Shares	Sole	2025-08-06
2025-03-31	$292,937	30,868	+0.7%	Shares	Sole	2025-05-09
2024-12-31	$423,080	30,658	-2.0%	Shares	Sole	2025-02-10
2024-09-30	$475,768	31,280	+4.3%	Shares	Sole	2024-10-18
2024-06-30	$143,100	30,000	-3.2%	Shares	Sole	2024-07-31
2024-03-31	$210,422	30,990	0.0%	Shares	Sole	2024-04-29
2023-12-31	$151,541	30,990	0.0%	Shares	Sole	2024-02-06
2023-09-30	$105,985	30,990	+3.3%	Shares	Sole	2023-10-23
2023-06-30	$143,400	30,000	0.0%	Shares	Sole	2023-08-10
2023-03-31	$126,600	30,000	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.